Journal article icon

Journal article

Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection

Abstract:
Context: Pheochromocytomas and paragangliomas (PPGL) are rare endocrine tumors with high heritability. Carriers of pathogenic variants (PVs) in susceptibility genes face a lifelong risk of recurrence or metastatic disease. Quality of life (QoL) in patients with PPGL, a history of PPGL and PV carriers, remains insufficiently studied. Methods: We assessed patient-reported QoL in patients with PPGL before and after surgery and in carriers of susceptibility PVs for the development of PPGLs within the prospective ProsPheo study. QoL was evaluated using standardized questionnaires (SF-12, PHQ-D, and GAD-7). Results: A total of 202 participants were analyzed. SF-12 physical component summary scores (PCS) differed significantly across subgroups (P = .006), with the lowest PCS scores in patients with metastatic PPGL (40.3) and unresected head and neck paragangliomas (HNPGL) (40.0), compared with PV carriers after curative PPGL resection (50.2). Within metastatic disease, hormonally active tumors showed lower PCS scores than inactive tumors (36.9 vs 46.2; P = .03). Perceived physical health in carriers of a PV without history of a PPGL was significantly lower compared to the age-matched general population. Mental health was not significantly impaired across all subgroups. Clinically relevant anxiety was reported in 15.2% of PV carriers and 21.7% of patients with unresected HNPGLs, compared with about 5.9% in the general population. Conclusions: Patient-reported physical health was reduced in patients with metastatic PPGLs, unresected HNPGLs, and PV carriers without prior PPGL, whereas patients after curative PPGL resection reported QoL comparable to the general population, regardless of PV status, suggesting that annual follow-up has minimal impact on QoL.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1093/ejendo/lvag003

Authors

More by this author
Role:
Author
ORCID:
0000-0003-4555-8334
More by this author
Role:
Author
ORCID:
0000-0002-3499-5910
More by this author
Role:
Author
ORCID:
0000-0003-0772-1604
More by this author
Role:
Author
ORCID:
0000-0002-8283-7861


More from this funder
Funder identifier:
https://ror.org/011cav305
More from this funder
Funder identifier:
https://ror.org/018mejw64


Publisher:
Oxford University Press
Journal:
European journal of endocrinology More from this journal
Volume:
194
Issue:
2
Pages:
80-90
Publication date:
2026-01-12
Acceptance date:
2025-12-29
DOI:
EISSN:
1479-683X
ISSN:
0804-4643


Language:
English
Keywords:
Pubs id:
2361011
UUID:
uuid_3357a2c4-7f34-479b-beea-ca1689385222
Local pid:
pubs:2361011
Source identifiers:
3725520
Deposit date:
2026-02-04
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP